Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
- Drug Discovery
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 28619
Chromatin is the combination of DNA and proteins that make up the contents of the nucleus of a cell. The primary functions of chromatin are 1) to package DNA into a smaller volume to fit in the cell, 2) to strengthen the DNA to allow mitosis, 3) to prevent DNA damage, and 4) to control gene expression and DNA replication.
A nucleosome is the basic unit of DNA packaging in eukaryotes, consisting of a segment of DNA wound in sequence around eight histone protein cores.
In biology, histones are highly alkaline proteins found in eukaryotic cell nuclei that package and order the DNA into structural units called nucleosomes.
W02005/019826 AI Worldwide Detection of Histone Modifications in Cell-Free Nucleosomes
Priority Date Application No. Publication No.
W02005/019826 AI National phase
IPSCIO Record ID: 4252
IPSCIO Record ID: 27792
IPSCIO Record ID: 269
Method for Determining Chromatin Structure
Priority Date 05/07/2001
Application No. PCT/GB02/03080
Publication No. WO202GB03080 20020704
Case Status Pending
Â· GeneICE as exemplified by patent nos. WO0102019, WO03033701 AND WO2004050885
Â· The peptide therapeutic compound licensed from Cancer Research Technology (CRT) as exemplified by Patent No. WO2008113770.
IPSCIO Record ID: 344585
The patents are titled
Transformed Myeloma Cell-Line and a Process for the Expression of a Gene Coding for a Eukaryotic Polypeptide employing same;
Recombinant DNA Sequences, Vectors containing them and Method for the use thereof;
Recombinant DNA Product and Processes using it , and,
Recombinant DNA Methods, Vectors and Host Cells.
Product means DNA/histone directed antibody of human or chimeric origin, in combination with radio isotope or another component, of which antibody Licensee is the proprietor and which is obtained by the expression of any one gene or of any combination of genes by use of the Materials.
System means the glutamine synthetase gene expression system of which Licensor is the proprietor, as the same is described in the Intellectual Property.